tiprankstipranks
Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
PremiumPress ReleasesAnavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
1M ago
Anavex initiates placebo-controlled U.S. Phase 2 trial of ANAVEX3-71
PremiumThe Fly
Anavex initiates placebo-controlled U.S. Phase 2 trial of ANAVEX3-71
1M ago
SHAREHOLDER ALERT: Potential Recovery for Anavex Life Sciences Corp. (AVXL) Investors
PremiumClass Action
SHAREHOLDER ALERT: Potential Recovery for Anavex Life Sciences Corp. (AVXL) Investors
2M ago
AVXL Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsAVXL Upcoming Earnings Report: What to Expect?
2M ago
Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024
PremiumPress Releases
Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024
3M ago
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
3M ago
Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
PremiumPress ReleasesAnavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
3M ago
Anavex announces U.S phase 2 trial of ANAVEX 3-71
PremiumThe Fly
Anavex announces U.S phase 2 trial of ANAVEX 3-71
3M ago
Anavex announces grant of U.S. patent covering blarcamesine
PremiumThe Fly
Anavex announces grant of U.S. patent covering blarcamesine
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100